Company intelligence / Profile preview

Cell Culture Service GmbH

Hamburg, Germany

Ownership: Private
Development stage: Other

Overview

Cell Culture Service GmbH (CCS) was a Hamburg-based CRO specializing in custom cell culture services for drug discovery. Acquired by Evotec AG on January 3, 2013, for approximately €1.2M initial cash plus earn-out, CCS operated subsidiaries in the US and provided tailor-made recombinant cell lines, assay-ready frozen cells, qualified membranes, and proteins for major pharma and biotech clients.

Industry: Drug Discovery Services

Partnerships

CEVEC PharmaTCS Cellworks Ltd

Beyond the preview

Go deeper on Cell Culture Service GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell Culture Service GmbH.

Explore the full profile